PURPOSE: An Ilium-derived bone marrow plasma for treating shoulder joint damage is provided to lower recurrence of damage after surgery and increase repair rate. CONSTITUTION: An ilium-derived bone marrow plasma for treating shoulder joint damage is transparent supernatant which is obtained after centrifugation. A pharmaceutical composition for treating shoulder damage contains one or more kinds selected among cytokine IL-12(P40), IP-10 and RANTES and pharmaceutically acceptable carrier. The pharmaceutical composition is used in the form of skin external formulation.
申请公布号
KR20090112908(A)
申请公布日期
2009.10.29
申请号
KR20080038686
申请日期
2008.04.25
申请人
JB STEM CELL INSTITUTE, INC.
发明人
MOON, YOUNG LAE;SONG, CHANG HUN;LEE, HYUN JU;JANG, SOO JEONG;JO, SEUNG HWAN